Environmental isocyanate-induced asthma: Morphologic and pathogenetic aspects of an increasing occupational disease

International Journal of Environmental Research and Public Health

Volumn 8, Issue 9, 2011, Pages 3672-3687

  Fisseler Eckhoff, Annette ^a   Bartsch, Holger ^a   Zinsky, Rica ^a   Schirren, Joachim ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Clinical findings; Genetic predisposition; Isocyanate; Occupational asthma; Occupational disease; Pathological findings

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ISOCYANATE;

ALLERGIC REACTION; ANAMNESIS; GENETIC PREDISPOSITION; HEREDITY; HUMAN; IMMUNOLOGICAL PROCEDURES; INHALATION TEST; MEDICAL EXAMINATION; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PROVOCATION TEST; REVIEW; SPIROMETRY; WORK ENVIRONMENT;

EID: 80053220693     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8093672     Document Type: Review

References (81)

1. International Labour Organization (ILO). Work-Related Fatalities Reach 2 Million Annually; ILO: Geneva, Switzerland, 2002; Avaiable online: http://www.ilo.org/global/about-the-ilo/press-andmedia-centre/press-releases/WCMS_007789/lang--en/index.htm (accessed on 27 February 2011).
2. Ayres, J.G.; Boyd, R.; Cowie, H.; Hurley, J.F. Costs of occupational asthma in the UK. Thorax 2011, 66, 128-133.
3. Tarlo, S.M.; Broder, I. Irritant-induced occupational asthma. Chest 1989, 96, 297-300.
4. Sastre, J.; Vandenplas, O.; Park, H.S. Pathogenesis of occupational asthma. Eur. Respir. J. 2003, 22, 364-373.
5. Malo, J.-L.; Lemière, C.; Gautrin, D.; Labrecque, M. Occupational asthma. Curr. Opin. Pulm. Med. 2004, 10, 57-61.
6. Dykewicz, M.S. Occupational asthma: Current concepts in pathogenesis, diagnosis, and management. J. Allergy Clin. Immunol. 2009, 123, 519-528; quiz 529-530.
7. Pisati, G.; Baruffini, A.; Bernabeo, F.; Cerri, S.; Mangili, A. Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure. Int. Arch. Occup. Environ. Health 2007, 80, 298-305.
8. Piirilä, P.L.; Meuronen, A.; Majuri, M.-L.; Luukkonen, R.; Mäntylä, T.; Wolff, H.J.; Nordman, H.; Alenius, H.; Laitinen, A. Inflammation and functional outcome in diisocyanateinduced asthma after cessation of exposure. Allergy 2008, 63, 583-591.
9. Liu, Q.; Wisnewski, A.V. Recent developments in diisocyanate asthma. Ann. Allergy Asthma Immunol. 2003, 90, 35-41.
10. Wisnewski, A.V. Developments in laboratory diagnostics for isocyanate asthma. Curr. Opin. Allergy Clin. Immunol. 2007, 7, 138-145.
11. Baur, X. Isocyanates: Occupational exposures and disorders. Pneumologie 2003, 57, 526-531.
12. Baur, X.; Budnik, L.T. New data on occupational exposure to isocyanates. Pneumologie 2009, 63, 656-661.
13. BAuA-TRGS 430 Isocyanate-Exposition und Überwachung/Technische Regeln für Gefahrstoffe (TRGS)/Gefahrstoffe/Themen von A-Z/Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Technische Regel für Gefahrstoffe 430; BAuA: Dortmund, Germany, 2009; Available online: http://www.baua.de/de/Themen-von-A-Z/Gefahrstoffe/TRGS/TRGS-430_content.html (accessed September 6 2011).
14. Cocker, J. Biological monitoring for isocyanates. Ann. Occup. Hyg. 2011, 55, 127-131.
15. Mishra, P.K.; Samarth, R.M.; Pathak, N.; Jain, S.K.; Banerjee, S.; Maudar, K.K. Bhopal Gas Tragedy: Review of clinical and experimental findings after 25 years. Int. J. Occup. Med. Environ. Health 2009, 22, 193-202.
16. Lemière, C.; Romeo, P.; Chaboillez, S.; Tremblay, C.; Malo, J.-L. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J. Allergy Clin. Immunol. 2002, 110, 641-646.
17. Bakerly, N.D.; Moore, V.C.; Vellore, A.D.; Jaakkola, M.S.; Robertson, A.S.; Burge, P.S. Fifteen-year trends in occupational asthma: Data from the Shield surveillance scheme. Occup. Med. (London) 2008, 58, 169-174.
18. Baur, X. I are we closer to developing threshold limit values for allergens in the workplace? Ann. Allergy Asthma Immunol. 2003, 90, 11-18.
19. Dragos, M.; Jones, M.; Malo, J.-L.; Ghezzo, H.; Gautrin, D. Specific antibodies to diisocyanate and work-related respiratory symptoms in apprentice car-painters. Occup. Environ. Med. 2009, 66, 227-234.
20. Jones, M.G.; Floyd, A.; Nouri-Aria, K.T.; Jacobson, M.R.; Durham, S.R.; Taylor, A.N.; Cullinan, P. Is occupational asthma to diisocyanates a non-IgE-mediated disease? J. Allergy Clin. Immunol. 2006, 117, 663-669.
21. Ye, Y.-M.; Kim, C.-W.; Kim, H.-R.; Kim, H.-M.; Suh, C.-H.; Nahm, D.-H.; Park, H.-S.; Redlich, C.A.; Wisnewski, A.V. Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma. J. Allergy Clin. Immunol. 2006, 118, 885-891.
22. Redlich, C.A.; Karol, M.H. Diisocyanate asthma: Clinical aspects and immunopathogenesis. Int. Immunopharmacol. 2002, 2, 213-224.
23. Wisnewski, A.V.; Jones, M. Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease? Clin. Exp. Allergy 2010, 40, 1155-1162.
24. Mapp, C.E.; Boschetto, P.; Miotto, D.; de Rosa, E. Asthma induced by isocyanates: A model of IgE-independent asthma. Acta Biomed. 2005, 76(Suppl 2), 15-19.
25. Fabbri, L.M.; Picotti, G.; Mapp, C.E. Late asthmatic reactions, airway inflammation and chronic asthma in TDI sensitized subjects. Eur. Respir. J. 1991, 13(Suppl), s136-s138.
26. Fabbri, L.M.; Maestrelli, P.; Saetta, M.; Mapp, C.E. Airway inflammation during late asthmatic reactions induced by toluene diisocyanate. Am. Rev. Respir. Dis. 1991, 143, S37-S38.
27. Saetta, M.; di Stefano, A.; Maestrelli, P.; de Marzo, N.; Milani, G.F.; Pivirotto, F.; Mapp, C.E.; Fabbri, L.M. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am. Rev. Respir. Dis. 1992, 145, 160-168.
28. Lange, R.W.; Lantz, R.C.; Stolz, D.B.; Watkins, S.C.; Sundareshan, P.; Lemus, R.; Karol, M.H. Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells. Toxicol. Sci. 1999, 50, 64-71.
29. Pons, F.; Fischer, A.; Frossard, N.; Lugnier, A. Effect of toluene diisocyanate and its corresponding amines on viability and growth of human lung fibroblasts in culture. Cell Biol. Toxicol. 1999, 15, 333-340.
30. Matheson, J.M.; Johnson, V.J.; Vallyathan, V.; Luster, M.I. Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma. Toxicol. Sci. 2005, 84, 88-98.
31. Johnson, V.J.; Yucesoy, B.; Reynolds, J.S.; Fluharty, K.; Wang, W.; Richardson, D.; Luster, M.I. Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice. J. Immunol. 2007, 179, 1864-1871.
32. Marek, W.; Mensing, T.; Riedel, F.; Viso, N.; Marczynski, B.; Baur, X. Hexamethylene diisocyanate induction of transient airway hyperresponsiveness in guinea pigs. Respiration 1997, 64, 35-44.
33. Svensson-Elfsmark, L.; Koch, B.L.; Gustafsson, A.; Bucht, A. Rats repeatedly exposed to toluene diisocyanate exhibit immune reactivity against methyl isocyanate-protein conjugates. Int. Arch. Allergy Immunol. 2009, 150, 229-236.
34. Pauluhn, J. Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): Impact of vehicle for topical induction. Regul. Toxicol. Pharmacol. 2008, 50, 144-154.
35. Fabbri, L.M.; Mapp, C. Bronchial hyperresponsiveness, airway inflammation and occupational asthma induced by toluene diisocyanate. Clin. Exp. Allergy 1991, 21 Suppl 1, 42-47.
36. Fabbri, L.M.; Saetta, M.; Picotti, G.; Mapp, C.E. Late asthmatic reactions, airway inflammation and chronic asthma in toluene-diisocyanate-sensitized subjects. Respiration 1991, 58(Suppl 1), 18-21.
37. Saetta, M.; Maestrelli, P.; di Stefano, A.; de Marzo, N.; Milani, G.F.; Pivirotto, F.; Mapp, C.E.; Fabbri, L.M. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am. Rev. Respir. Dis. 1992, 145, 169-174.
38. Saetta, M.; Maestrelli, P.; Turato, G.; Mapp, C.E.; Milani, G.; Pivirotto, F.; Fabbri, L.M.; di Stefano, A. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am. J. Respir. Crit. Care Med. 1995, 151, 489-494.
39. Maestrelli, P.; Del Prete, G.F.; De Carli, M.; D'Elios, M.M.; Saetta, M.; Di Stefano, A.; Mapp, C.E.; Romagnani, S.; Fabbri, L.M. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand. J. Work Environ. Health 1994, 20, 376-381.
40. Boulet, L.-P.; Lemière, C.; Gautrin, D.; Cartier, A. New insights into occupational asthma. Curr. Opin. Allergy Clin. Immunol. 2007, 7, 96-101.
41. Hur, G.-Y.; Koh, D.-H.; Choi, G.-S.; Park, H.-J.; Choi, S.-J.; Ye, Y.-M.; Kim, K.-S.; Park, H.-S. Clinical and immunologic findings of methylene diphenyl diisocyanate-induced occupational asthma in a car upholstery factory. Clin. Exp. Allergy 2008, 38, 586-593.
42. Wisnewski, A.V.; Liu, Q.; Liu, J.; Redlich, C.A. Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates. Clin. Exp. Allergy 2008, 38, 957-967.
43. Maestrelli, P.; Di Stefano, A.; Occari, P.; Turato, G.; Milani, G.; Pivirotto, F.; Mapp, C.E.; Fabbri, L.M.; Saetta, M. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am. J. Respir. Crit. Care Med. 1995, 151, 607-612.
44. Maestrelli, P.; Occari, P.; Turato, G.; Papiris, S.A.; Di Stefano, A.; Mapp, C.E.; Milani, G.F.; Fabbri, L.M.; Saetta, M. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin. Exp. Allergy 1997, 27, 1292-1298.
45. Wisnewski, A.V.; Herrick, C.A.; Liu, Q.; Chen, L.; Bottomly, K.; Redlich, C.A. Human gamma/delta T-cell proliferation and IFN-gamma production induced by hexamethylene diisocyanate. J. Allergy Clin. Immunol. 2003, 112, 538-546.
46. Fabbri, L.M.; Boschetto, P.; Zocca, E.; Milani, G.; Pivirotto, F.; Plebani, M.; Burlina, A.; Licata, B.; Mapp, C.E. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am. Rev. Respir. Dis. 1987, 136, 36-42.
47. Park, H.; Jung, K.; Kim, H.; Nahm, D.; Kang, K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin. Exp. Allergy 1999, 29, 1395-1401.
48. Lee, Y.-M.; Kim, H.-A.; Park, H.-S.; Lee, S.-K.; Nahm, D.-H. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: Effect of pro-inflammatory cytokines. J. Korean Med. Sci. 2003, 18, 809-812.
49. Park, H.-S.; Kim, H.-A.; Jung, J.-W.; Kim, Y.-K.; Lee, S.-K.; Kim, S.-S.; Nahm, D.-H. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clin. Exp. Allergy 2003, 33, 113-118.
50. Piirilä, P.; Lauhio, A.; Majuri, M.-L.; Meuronen, A.; Myllärniemi, M.; Tervahartiala, T.; Vuorinen, K.; Laitinen, A.; Alenius, H.; Kinnula, V.L., et al. Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma. Allergy 2010, 65, 61-68.
51. Zocca, E.; Fabbri, L.M.; Boschetto, P.; Plebani, M.; Masiero, M.; Milani, G.F.; Pivirotto, F.; Mapp, C.E. Leukotriene B4 and late asthmatic reactions induced by toluene diisocyanate. J. Appl. Physiol. 1990, 68, 1576-1580.
52. Scheerens, H.; Buckley, T.L.; Muis, T.; van Loveren, H.; Nijkamp, F.P. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br. J. Pharmacol. 1996, 119, 1665-1671.
53. Mapp, C.E.; Lucchini, R.E.; Miotto, D.; Chitano, P.; Jovine, L.; Saetta, M.; Maestrelli, P.; Springall, D.R.; Polak, J.; Fabbri, L.M. Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways. Am. J. Respir. Crit. Care Med. 1998, 158, 263-269.
54. Redlich, C.A. Skin exposure and asthma: Is there a connection? Proc. Am. Thorac. Soc. 2010, 7, 134-137.
55. Redlich, C.A.; Herrick, C.A. Lung/skin connections in occupational lung disease. Curr. Opin. Allergy Clin. Immunol. 2008, 8, 115-119.
56. de Vooght, V.; Haenen, S.; Verbeken, E.; Nemery, B.; Hoet, P.H.M.; Vanoirbeek, J.A.J. Successful transfer of chemical-induced asthma by adoptive transfer of low amounts of lymphocytes in a mouse model. Toxicology 2011, 279, 85-90.
57. Wisnewski, A.V.; Liu, Q.; Liu, J.; Redlich, C.A. Glutathione protects human airway proteins and epithelial cells from isocyanates. Clin. Exp. Allergy 2005, 35, 352-357.
58. Ye, Y.-M.; Nahm, D.-H.; Kim, C.-W.; Kim, H.-R.; Hong, C.-S.; Park, C.-S.; Suh, C.-H.; Park, H.-S. Cytokeratin autoantibodies: Useful serologic markers for toluene diisocyanate-induced asthma. Yonsei Med. J. 2006, 47, 773-781.
59. Wisnewski, A.V.; Liu, J.; Redlich, C.A. Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate. Anal. Biochem. 2010, 400, 251-258.
60. Wisnewski, A.V.; Stowe, M.H.; Cartier, A.; Liu, Q.; Liu, J.; Chen, L.; Redlich, C.A. Isocyanate vapor-induced antigenicity of human albumin. J. Allergy Clin. Immunol. 2004, 113, 1178-1184.
61. Beck, L.A.; Leung, D.Y. Allergen sensitization through the skin induces systemic allergic responses. J. Allergy Clin. Immunol. 2000, 106, S258-S263.
62. Piirilä, P.; Wikman, H.; Luukkonen, R.; Kääriä, K.; Rosenberg, C.; Nordman, H.; Norppa, H.; Vainio, H.; Hirvonen, A. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001, 11, 437-445.
63. Mapp, C.E.; Fryer, A.A.; De Marzo, N.; Pozzato, V.; Padoan, M.; Boschetto, P.; Strange, R.C.; Hemmingsen, A.; Spiteri, M.A. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J. Allergy Clin. Immunol. 2002, 109, 867-872.
64. Fryer, A.A.; Bianco, A.; Hepple, M.; Jones, P.W.; Strange, R.C.; Spiteri, M.A. Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. 2000, 161, 1437-1442.
65. Broberg, K.; Tinnerberg, H.; Axmon, A.; Warholm, M.; Rannug, A.; Littorin, M. Influence of genetic factors on toluene diisocyanate-related symptoms: Evidence from a cross-sectional study. Environ. Health 2008, 7, 15.
66. Broberg, K.E.; Warholm, M.; Tinnerberg, H.; Axmon, A.; Jönsson, B.A.; Sennbro, C.J.; Littorin, M.; Rannug, A. The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene diisocyanate. Pharmacogenet. Genomics 2010, 20, 104-111.
67. Mapp, C.E.; Beghè, B.; Balboni, A.; Zamorani, G.; Padoan, M.; Jovine, L.; Baricordi, O.R.; Fabbri, L.M. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin. Exp. Allergy 2000, 30, 651-656.
68. Rihs, H.P.; Barbalho-Krölls, T.; Huber, H.; Baur, X. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am. J. Ind. Med. 1997, 32, 522-527.
69. Choi, J.-H.; Lee, K.-W.; Kim, C.-W.; Park, C.-S.; Lee, H.-Y.; Hur, G.-Y.; Kim, S.-H.; Hong, C.-S.; Jang, A.-S.; Park, H.-S. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Int. Arch. Allergy Immunol. 2009, 150, 156-163.
70. Beghé, B.; Padoan, M.; Moss, C.T.; Barton, S.J.; Holloway, J.W.; Holgate, S.T.; Howell, W.M.; Mapp, C.E. Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy 2004, 59, 61-64.
71. Kim, S.-H.; Cho, B.-Y.; Park, C.-S.; Shin, E.-S.; Cho, E.-Y.; Yang, E.-M.; Kim, C.-W.; Hong, C.-S.; Lee, J.-E.; Park, H.-S. Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin. Exp. Allergy 2009, 39, 203-212.
72. Wikman, H.; Piirilä, P.; Rosenberg, C.; Luukkonen, R.; Kääriä, K.; Nordman, H.; Norppa, H.; Vainio, H.; Hirvonen, A. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 2002, 12, 227-233.
73. Bernstein, D.I.; Wang, N.; Campo, P.; Chakraborty, R.; Smith, A.; Cartier, A.; Boulet, L.-P.; Malo, J.-L.; Yucesoy, B.; Luster, M., et al. Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann. Allergy Asthma Immunol. 2006, 97, 800-806.
74. Bernstein, D.I.; Kissling, G.E.; Khurana Hershey, G.; Yucesoy, B.; Johnson, V.J.; Cartier, A.; Gautrin, D.; Sastre, J.; Boulet, L.-P.; Malo, J.-L., et al. Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α. J. Allergy Clin. Immunol. 2011, 128, 418-420.
75. Baur, X. Bronchial challenge tests. Pneumologie 2011, 65, 340-346.
76. Tarlo, S.M.; Balmes, J.; Balkissoon, R.; Beach, J.; Beckett, W.; Bernstein, D.; Blanc, P.D.; Brooks, S.M.; Cowl, C.T.; Daroowalla, F., et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008, 134, S1-S41.
77. Banks, D.E. Use of the specific challenge in the diagnosis of occupational asthma: A "gold standard" test or a test not used in current practice of occupational asthma? Curr. Opin. Allergy Clin. Immunol. 2003, 3, 101-107.
78. Sastre, J.; Fernández-Nieto, M.; Novalbos, A.; de las Heras, M.; Cuesta, J.; Quirce, S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest 2003, 123, 1276-1279.
79. Caron, S.; Boileau, J.-C.; Malo, J.-L.; Leblond, S. New methodology for specific inhalation challenges with occupational agents. Respir. Res. 2010, 11, 72.
80. Piirilä, P.L.; Nordman, H.; Keskinen, H.M.; Luukkonen, R.; Salo, S.P.; Tuomi, T.O.; Tuppurainen, M. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am. J. Respir. Crit. Care Med. 2000, 162, 516-522.
81. Palikhe, N.S.; Kim, J.-H.; Park, H.-S. Biomarkers predicting isocyanate-induced asthma. Allergy Asthma Immunol. Res. 2011, 3, 21-26.